BIOAF
biOasis Technologies Inc

44
52W High
$0.0006
Volume
74,000.00
52W Low
$0.00
Price
$0.0001
Open
$0.0001
BIOAF Fundamentals
50D MA
$0.00
Beta
9.15
Avg. Volume
0.00
Loading...
Loading...

About

biOasis Technologies, Inc. operates as a biopharmaceutical company. It focuses on research and development for the diagnosis and treatment of neurological disease and disorders such as brain cancers, neurodegenerative diseases, and metabolic disorders. Its products include the Transcend program as its proprietary carrier, p97 and imaging agents across the blood brain barrier. The company was founded by Robin B. Hutchison on November 3, 2006 and is headquartered in New Haven, CT.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is the 52-week high for Bioasis Technologies Inc?
What is Bioasis Technologies Inc stock price today?

Latest BIOAF News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.